3h
Zacks.com on MSNTempus AI Falls 15% on Weak Q4 but EBITDA View Strong: Buy the Dip?The acquisition of Ambry Genetics strengthens Tempus AI's genomics capabilities by adding a West Coast lab and expanding ...
We recently published an article titled Two of 10 Worst-Performing Stocks Fall to All-Time Lows on Tuesday. In this article, ...
Tempus AI's Q4 financials were slightly below expectations but aligned with preliminary results. See why I remain bullish on ...
21h
Investor's Business Daily on MSNTempus AI Reverses 192% Run. Why At Least One Analyst Remains A Believer."We believe guidance for the year is appropriately set to be achieved and that Tempus has a very long revenue growth runway ahead of it," he said in a report. "Still, shares are o ...
Our Tempus AI Inc share price forecast data is based on consensus analyst prediction, covering public companies earnings per share and revenue. Assess the Tempus AI share price predictions. View ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results